CMA: pay-for-delay settlement “restrictive in its own right”
Competition Appeal Tribunal at Victoria House in London (Credit: iStock/Paul The Archivist)
In its opening statement at the Competition Appeal Tribunal today, the UK competition authority said that pay-for-delay agreements between an antidepressant patent holder and generics manufacturers were “by nature antithetical to the competitive process”.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now